Serum CCL20: A novel potential marker of cardiovascular risk in alopecia areata patients
Background Alopecia areata (AA) is a prevalent autoimmune skin disease that may be associated with systemic disorders. The connection between cardiovascular risks and AA is not widely investigated. Chemokine (C-C motif) ligand 20 (CCL20) has been found to be related to cardiovascular comorbidities....
Saved in:
Main Authors: | Ahmed M Hamed (Author), Amal M Abdelmaksoud (Author), Asmaa A Elfallah (Author), Enas M Sweed (Author), Samah E Ibrahim (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic markers for severity, activity, and recurrence of alopecia areata
by: Neveen E Sorour, et al.
Published: (2021) -
Serum Vitamin D in patients with alopecia areata
by: Ola Ahmed Bakry, et al.
Published: (2016) -
Evaluation of Serum Inflammatory Markers and Their Relationship to Treatment Response in Alopecia Areata Patients
by: Icim Komurcugil, et al.
Published: (2024) -
Total serum immunoglobulin E in patients with alopecia areata
by: Ola Ahmed Bakry, et al.
Published: (2014) -
Serum Zinc Concentration in Patients with Alopecia Areata
by: Jovan Lalosevic, et al.
Published: (2023)